Epidemiologic assessment of benzodiazepine exposure among suicide deaths in Colorado, 2015–2017
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Background: Suicide rates have been climbing in the U.S., particularly in Rocky Mountain states such as Colorado. Benzodiazepines have been linked with suicidal ideation, but there have been few population level assessments of this link. We conducted a public health assessment to determine the epidemiology and prevalence of recent benzodiazepine exposure, among suicide deaths in Colorado from 2015 to 17. Methods: This epidemiologic assessment linked Colorado’s Prescription Drug Monitoring Program, death certificate data, and Violent Death Reporting System to determine patterns of benzodiazepine exposure among suicide deaths in Colorado between 2015 and 2017. Recent benzodiazepine exposure was defined as receiving a prescription within 30 days of death or having a positive toxicology screen post-mortem. Results: Among the 3465 suicide deaths in Colorado between 2015 and 2017, 20% had recent benzodiazepine exposure, and nearly 50% of those also had recent opioid exposure. Recent benzodiazepine exposure was more common among females than males (34% versus 16%). Among suicide deaths, those who died via drug overdose were more likely to have had recent benzodiazepine exposure (48%), compared to suicides by firearm (17%), hanging/asphyxiation (13%) and all other methods (approximately 20%). Conclusions: Benzodiazepines have been linked to suicidal ideation, but population level assessments of benzodiazepine exposure among suicide deaths are rare. Our epidemiologic assessment indicates a relatively high prevalence of recent benzodiazepine exposure that warrants further investigation from both clinical and public health perspectives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In an epidemiological study in Colorado from 2015 to 2017, 20% of the 3465 suicides in that period were decedents who had a recent benzodiazepine exposure.”
From Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey (2022) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Benzodiazepine Use in the United States
Olfson, M., King, M., & Schoenbaum, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1763 · Cited by 786
Stone, D. M., Simon, T. R., Fowler, K. A., Kegler, S. R., Yuan, K., Holland, K. M., Ivey-Stephenson, A. Z., & Crosby, A. E. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6722a1 · Cited by 634
National Strategy for Suicide Prevention: Goals and Objectives for Action: (415652005-001)
US Department of Health and Human Services; Substance Abuse and Mental Health Services Administration (2001) · PsycEXTRA Dataset · doi:10.1037/e415652005-001 · Cited by 459
National Strategy for Suicide Prevention: Goals and Objectives for Action
Satcher, D. S. (2003) · Cited by 392
Benzodiazepine Use and Misuse Among Adults in the United States
Maust, D. T., Lin, L. A., & Blow, F. C. (2019) · Psychiatric Services · doi:10.1176/appi.ps.201800321 · Cited by 337
National Strategy for Suicide Prevention: Goals and Objectives for Action.
Silverman, M. M. (2001) · Cited by 285
Management of benzodiazepine misuse and dependence
Brett, J., & Murnion, B. (2015) · Australian Prescriber · doi:10.18773/austprescr.2015.055 · Cited by 260
Vinkers, C. H., & Olivier, B. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/416864 · Cited by 195
Usage of benzodiazepines: A review
Donoghue, J., & Lader, M. (2010) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651500903447810 · Cited by 156
Consequences of the 1989 New York State Triplicate Benzodiazepine Prescription Regulations
Weintraub, M. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470170080028 · Cited by 147
Research works printed but not linked: 4
- Opioid Overdose Prevention Unit Colorado Opioid Data Profile. Colorado Department of Public Health and Environment 2018
- World Health Organization Suicide prevention: a global imperative 2014 Geneva WHO Press
- Tilly J Skowronski S Ruiz S “The Opioid Public Health Emergency and Older Adults.” Administration for Community Living 2017
- US. Food and Drug Adminisration FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning 2016
Cited by
Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey
Reid Finlayson, A. J., Macoubrie, J., Huff, C., Foster, D. E., & Martin, P. R. (2022) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253221082386 · Cited by 40
Yazdipour, A. B., Moshiri, M., Dadpour, B., Sarbaz, M., Miri, H. H., Khaniki, S. H., & Kimiafar, K. (2022) · Health Science Reports · doi:10.1002/hsr2.587 · Cited by 14
“Numerous studies have been performed in this regard in the past, and their findings are consistent with the findings of the present study.(20,25,27,32) The findings of the present study showed that poisoning by narcotics such as Opium (T40.”
ResultAntonio, A. D. S., Bhering, C. D. A., Wurzler, G. T., Carvalhosa, D. R., Jardim, A. C., Chalom, M. Y., Neto, F. R. D. A., & Vanini, G. (2024) · Forensic Chemistry · doi:10.1016/j.forc.2024.100580 · Cited by 12
Yang, L., Roy, K., Ioka, S., Otani, R., Amezawa, M., Ishikawa, Y., Chérasse, Y., Kaushik, M. K., Klewe-Nebenius, D., Zhou, L., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1138666 · Cited by 10
Classifying coping strategies from suicide prevention safety plans
Daglas, Z., Lu, S., Gresham, D., Tatnell, R., Stanley, B., & Melvin, G. A. (2024) · Suicide and Life-Threatening Behavior · doi:10.1111/sltb.13039 · Cited by 9
Metadata
- Authors
- Ghosh, T., Bol, K., Butler, M., Gabella, B., Kingcade, A., Kaplan, G., & Myers, L.
- Affiliations
- Colorado Department of Public Health and Environment (US)
- Corresponding author
- Ghosh, Tista
- Venue
- BMC Public Health
- Published
- 2020-07-22
- Volume
- 20
- Issue
- 1
- Pages
- 1149-1149
- ISSN
- 1471-2458 (ISSN-L)
- PMC
- PMC7374952
- OpenAlex
- W3045343244
- Cited by
- 17
- References
- 22
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 3 · 2023: 2 · 2022: 2 · 2021: 2
- FWCI
- 0.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- BMC Public Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Center for Chronic Disease Prevention and Health Promotion (5 NU17CE002719-03-00)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Keywords
- benzodiazepines, suicide mortality, opioid exposure, drug overdose, suicide methods, sex differences, prescription drug monitoring programs, toxicity screening, Colorado
- MeSH terms
- Adult, Analgesics, Opioid, Autopsy, Benzodiazepines, Colorado, Female, Humans, Male, Middle Aged, Drug Prescriptions, Public Health, Suicide, Prevalence, Self-Injurious Behavior, Suicidal Ideation, Drug Overdose
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epidemiologic assessment of benzodiazepine exposure among suicide deaths in Colorado, 2015–2017. https://app.cochat.ai/papers/10.1186/s12889-020-09250-y
- The paper
- Ghosh, T., Bol, K., Butler, M., Gabella, B., Kingcade, A., Kaplan, G., & Myers, L. (2020). Epidemiologic assessment of benzodiazepine exposure among suicide deaths in Colorado, 2015–2017. BMC Public Health. https://doi.org/10.1186/s12889-020-09250-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.